Research has identified EF-Tu as a surface molecule in Lactobacillus johnsonii NCC533 (La1) that mediates the bacterium's attachment to intestinal epithelial cells and mucins . Studies have confirmed the presence of EF-Tu on the surface of La1 through immunoblotting, electron microscopy, and enzyme-linked immunosorbent assays .
Key findings regarding the function of EF-Tu in Lactobacillus johnsonii:
Adhesion: EF-Tu acts as an adhesion factor, facilitating the binding of L. johnsonii to intestinal cells and mucins .
pH Dependence: The binding of EF-Tu to intestinal cells and mucins is pH-dependent .
Mucin Binding: EF-Tu plays a significant role in the mucin-binding capacity of L. johnsonii . Competition experiments have demonstrated that EF-Tu can prevent the binding of mucins to L. johnsonii bacteria .
Immunomodulation: EF-Tu can induce a pro-inflammatory response in intestinal cells in the presence of soluble CD14, suggesting its involvement in gut homeostasis .
Recombinant EF-Tu can be produced in other organisms like E. coli and then purified for use in experiments examining its properties . Recombinant EF-Tu from Lactobacillus reuteri is also available for purchase, with the following characteristics :
| Property | Value |
|---|---|
| Species reactivity | Lactobacillus reuteri |
| Molecular weight | 50.9 kD |
| Purity | >90% (SDS-PAGE) |
| Host | E. coli |
| Application | Activity not tested |
| KEGG ID | K02358 |
| UniProt ID | A5VJ92 |
| Gene ID | GeneID 77190802 |
| Storage temperature | -20°C |
Genetic engineering can modify Lactobacillus johnsonii to express specific proteins, enhancing its therapeutic potential . For example, a recombinant Lactobacillus johnsonii strain has been engineered to express bovine Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) to reduce postpartum uterine inflammation in bovines .
The recombinant L. johnsonii strain expressing GM-CSF showed the following effects :
Reduced levels of inflammatory markers (IL-6, IL-1β, TNF-α).
Decreased myeloperoxidase (MPO) activity and nitric oxide (NO) concentration.
Improved uterine morphology and reduced pathological damage.
Beneficial effects on bovine endometritis by reducing levels of inflammatory cytokines.
EF-Tu exhibits diverse "moonlighting" functions on the extracellular surface of both eukaryotic and prokaryotic cells, beyond its primary role in protein synthesis . These functions include interacting with membrane receptors and the extracellular matrix . For instance, EF-Tu of Mycoplasma pneumoniae binds fibronectin, while EF-Tu of Lactobacillus johnsonii mediates attachment to mucins . Additionally, recombinant EF-Tu of Pseudomonas aeruginosa binds human complement regulators, contributing to immune evasion .
KEGG: ljo:LJ_1009
STRING: 257314.LJ1009
Elongation Factor Tu (EF-Tu) is traditionally recognized as a cytoplasmic protein involved in protein synthesis, but in Lactobacillus johnsonii NCC533 (La1), it also functions as a surface-expressed molecule. Tandem mass spectrometry analysis has confirmed that EF-Tu is expressed on the La1 surface as an intact molecule, not as fragments. The surface localization has been verified through multiple techniques including immunoblotting experiments, electron microscopy, and enzyme-linked immunosorbent assays of live bacteria . The expression of EF-Tu at the bacterial surface represents a non-canonical function beyond its classical role in translation, suggesting evolutionary adaptations that may contribute to the ecological fitness of L. johnsonii in its host environment.
EF-Tu from L. johnsonii NCC533 (La1) demonstrates specific adhesin-like properties in the intestinal environment. Experimental evidence shows that recombinant La1 EF-Tu protein binds to intestinal epithelial cells (such as Caco-2 cells) and mucins. This binding capability is notably pH-dependent, suggesting a mechanism attuned to specific intestinal microenvironments. Competition experiments have further established that EF-Tu plays a significant role in La1's mucin binding capacity . Methodologically, these adhesive properties can be assessed through in vitro binding assays using recombinant EF-Tu protein and intestinal cell lines, with quantification via enzyme-linked immunosorbent assays or immunofluorescence microscopy.
Differentiating L. johnsonii from closely related species, particularly L. gasseri and L. taiwanensis, requires a combination of molecular and comparative genomics methods. Phylogenetic analysis using multiple gene sequences (16S rRNA, recA, pheS, pyrG, and tuf) provides initial species identification. DNA-DNA hybridization experiments confirm distinct but close relationships between these species. For more precise discrimination, Comparative Genomic Hybridization (CGH) using DNA microarrays designed for L. johnsonii can be employed . When specifically studying EF-Tu, researchers should sequence the tuf gene, which encodes for EF-Tu, and compare it with reference sequences. Additionally, terminal restriction fragment length polymorphism (tRFLP) can be used as part of the isolation procedure to identify L. johnsonii within a selected spectrum of lactic acid bacteria .
For optimal recombinant production of L. johnsonii EF-Tu, researchers should employ a methodological approach that preserves the protein's functional characteristics. The recommended procedure involves:
Gene amplification of the tuf gene from L. johnsonii genomic DNA using high-fidelity polymerase and specific primers designed to incorporate appropriate restriction sites.
Cloning into an expression vector with an inducible promoter and affinity tag (such as His-tag or GST-tag) for purification.
Expression in a suitable bacterial host system, with E. coli BL21(DE3) often preferred due to its reduced protease activity.
Optimization of induction conditions (temperature, IPTG concentration, and duration) to maximize soluble protein yield.
Purification via affinity chromatography, followed by size-exclusion chromatography to remove aggregates and obtain homogeneous protein.
For functional studies, it is critical to verify that the recombinant EF-Tu retains its native conformation and binding properties through circular dichroism spectroscopy and binding assays with intestinal cells and mucins . Tag removal may be necessary for some applications, particularly those involving immunological studies, to prevent interference with protein function or introduction of artificial immunogenic epitopes.
Analysis of the immunomodulatory effects of recombinant L. johnsonii EF-Tu requires a comprehensive experimental approach. Based on current research, EF-Tu can induce a proinflammatory response in HT29 cells in the presence of soluble CD14 . A systematic methodology should include:
Cell culture models: Employing intestinal epithelial cell lines (HT29, Caco-2) and immune cells (macrophages, dendritic cells) in co-culture systems.
Cytokine profiling: Measuring the induction of multiple cytokines (IL-6, IL-8, TNF-α, IL-10) using ELISA or cytometric bead arrays following exposure to recombinant EF-Tu.
Signaling pathway analysis: Investigating activation of NF-κB and MAPK pathways through Western blotting, reporter assays, or phosphoprotein arrays.
Dose-response relationships: Establishing optimal concentrations of recombinant EF-Tu for immunomodulatory effects.
Time-course experiments: Determining the kinetics of the immune response.
Receptor identification: Using blocking antibodies or knockout cell lines to identify the receptors involved (beyond CD14).
Researchers should include appropriate controls, such as heat-inactivated EF-Tu, other surface proteins from L. johnsonii, and EF-Tu from non-probiotic bacteria, to establish specificity of the observed effects .
Sequence homology: Comparing the amino acid sequence of EF-Tu across Lactobacillus species (L. acidophilus, L. paracasei, L. gasseri, L. reuteri) to identify conserved and variable regions that might explain functional differences .
Surface localization: Determining whether EF-Tu is consistently expressed on the surface of other Lactobacillus species using the same methodologies applied to L. johnsonii (immunoblotting, electron microscopy, and enzyme-linked immunosorbent assays) .
Binding properties: Comparing the adhesive capabilities of EF-Tu from different species to intestinal cells and mucins, including pH-dependency of binding.
Immunomodulatory potential: Assessing species-specific differences in the ability to induce cytokine responses.
Host specificity: Evaluating whether EF-Tu contributes to the observed host specificity of L. johnsonii strains, which form distinct clusters based on their host origin (human, chicken, or mouse) .
This comparative approach would require cloning, expression, and purification of EF-Tu from multiple Lactobacillus species, followed by functional assays under standardized conditions.
When investigating the pH-dependent binding of L. johnsonii EF-Tu to intestinal cells and mucins, researchers must carefully control several critical parameters:
pH range selection: Test a physiologically relevant pH gradient (pH 4.0-8.0) that encompasses the varying conditions throughout the gastrointestinal tract.
Buffer composition: Use buffers that maintain stable pH without interfering with protein-cell interactions (e.g., phosphate-buffered saline, HEPES, or MES buffers at appropriate pH values).
Mucin source and preparation: Employ both commercially available purified mucins and freshly isolated mucins from relevant species. Ensure proper solubilization and coating conditions for in vitro binding assays.
Cell model selection: Use intestinal epithelial cell lines (Caco-2, HT29) at appropriate differentiation stages, as differentiation affects mucin expression and composition.
Binding quantification: Implement multiple complementary techniques such as ELISA, surface plasmon resonance, and fluorescence-based assays with labeled recombinant EF-Tu.
Competition assays: Include unlabeled EF-Tu at various concentrations to demonstrate binding specificity .
Kinetic measurements: Determine association and dissociation rates at different pH values to characterize the binding dynamics.
Structural integrity verification: Confirm that pH changes do not affect EF-Tu structure using circular dichroism or fluorescence spectroscopy.
The experimental design should include appropriate controls such as other L. johnsonii surface proteins and EF-Tu from non-adhesive bacterial species to establish specificity of the observed pH-dependent interactions.
Designing experiments to study the host specificity of L. johnsonii EF-Tu requires a comprehensive approach that integrates genetic, structural, and functional analyses:
Strain collection and genomic analysis:
Recombinant protein production:
Express and purify EF-Tu from strains isolated from different hosts
Verify structural integrity through circular dichroism and thermal stability assays
Binding specificity assays:
Test binding of different EF-Tu variants to intestinal epithelial cells and mucins from corresponding host species
Conduct cross-binding experiments (e.g., human L. johnsonii EF-Tu binding to mouse intestinal cells)
Quantify binding affinities using surface plasmon resonance or similar techniques
Domain mapping:
Create chimeric proteins by swapping domains between EF-Tu variants from different hosts
Identify regions responsible for host-specific binding
In vivo colonization studies:
Generate L. johnsonii mutants with EF-Tu variants from different hosts
Assess colonization efficiency in different animal models
Monitor persistence through fecal sampling and quantitative PCR
This experimental framework would provide insights into whether EF-Tu contributes to the observed host specificity of L. johnsonii strains, which form distinct clusters based on their host origin .
When assessing the immunomodulatory effects of recombinant L. johnsonii EF-Tu, the following essential controls must be included to ensure valid and interpretable results:
Protein-specific controls:
Heat-denatured EF-Tu to distinguish structure-dependent effects
Purification tag-only protein to control for tag-induced effects
Size-matched unrelated protein purified using the same protocol
EF-Tu from non-probiotic bacteria (e.g., E. coli) to determine species-specific effects
Endotoxin controls:
Endotoxin-free preparation verification using LAL assay
Polymyxin B treatment to neutralize potential LPS contamination
TLR4 antagonist controls to distinguish EF-Tu effects from LPS effects
Cell system controls:
Pathway controls:
Specific pathway inhibitors (e.g., NF-κB inhibitors)
Receptor blocking antibodies
Knockdown/knockout cell lines for specific receptors or adaptor molecules
Validation controls:
Multiple cell lines to ensure cell-type independence of effects
Primary cells to confirm relevance beyond cell lines
Dose-response relationships to establish physiological relevance
Implementing these controls systematically will help distinguish specific immunomodulatory effects of L. johnsonii EF-Tu from non-specific effects or experimental artifacts.
Differentiating between direct and indirect immunomodulatory effects of L. johnsonii EF-Tu presents significant analytical challenges. To address this, researchers should implement a systematic approach:
Receptor identification studies:
Perform receptor blocking experiments using antibodies against potential receptors
Use receptor knockout cell lines
Conduct direct binding assays between purified EF-Tu and potential receptors
Employ proximity ligation assays to visualize receptor interactions in situ
Signaling pathway dissection:
Use specific inhibitors targeting different components of immune signaling pathways
Track activation kinetics through phosphorylation assays
Employ reporter cell lines for specific transcription factors (NF-κB, AP-1, IRF)
Conduct RNA-seq at early time points to identify primary response genes
Co-culture systems:
Design transwell experiments separating different cell types
Use conditioned media transfer between cell types
Employ cytokine neutralizing antibodies to block secondary effects
Compare results from monoculture vs. co-culture conditions
Temporal analysis:
Conduct detailed time-course experiments to separate early (likely direct) from late (possibly indirect) effects
Use protein synthesis inhibitors to distinguish effects requiring new protein synthesis
Monitor the sequential activation of different cell types in mixed cultures
The research has shown that EF-Tu can induce a proinflammatory response in HT29 cells in the presence of soluble CD14 , suggesting a direct effect through CD14-dependent pathways, but further studies are needed to fully characterize the mechanisms involved.
When analyzing host-specificity data of L. johnsonii strains, particularly in relation to EF-Tu function, several statistical approaches are recommended for robust interpretation:
Hierarchical clustering and principal component analysis (PCA):
Phylogenetic analyses:
Analysis of molecular variance (AMOVA):
Partition genetic variance within and among host-specific populations
Test significance of population structure using permutation tests
Discriminant analysis of principal components (DAPC):
Identify genetic variables that best explain host-specific clustering
Calculate membership probabilities for each strain to host-specific groups
Functional data analysis:
For binding assays comparing EF-Tu from different host-specific strains, use:
Two-way ANOVA with post-hoc tests for multiple comparisons
Linear mixed-effect models to account for batch effects and repeated measures
Non-parametric alternatives (Kruskal-Wallis, permutation tests) when assumptions are violated
Correlation analyses:
Use Mantel tests to correlate genetic distance matrices with functional distance matrices
Apply partial least squares regression to identify genetic variations associated with functional differences
These statistical approaches should be selected based on data structure and specific research questions, with appropriate correction for multiple testing when applicable.
When faced with conflicting data on the immunomodulatory effects of L. johnsonii EF-Tu, researchers should adopt a systematic reconciliation approach:
Methodological comparison and standardization:
Critically evaluate differences in experimental protocols (protein purification methods, endotoxin removal, cell models, incubation conditions)
Replicate key experiments using standardized protocols
Collaborate with laboratories reporting discrepant results to perform side-by-side comparisons
Strain-specific variation analysis:
Context-dependent effects assessment:
Dose-response and kinetic reconciliation:
Conduct comprehensive dose-response studies across a wide concentration range
Perform detailed time-course experiments to capture transient effects
Create mathematical models that might explain apparently conflicting observations as different aspects of a complex response
Meta-analysis approach:
Systematically review all available data
Apply appropriate statistical methods to integrate findings across studies
Identify moderator variables that might explain heterogeneity in results
Biological variance acknowledgment:
Consider that apparent contradictions may reflect genuine biological complexity
Design experiments to test whether EF-Tu effects are:
Cell-type specific
Species-specific
Dependent on microenvironmental factors
This structured approach allows researchers to determine whether conflicting data represent truly contradictory findings or simply different facets of EF-Tu's complex immunomodulatory activities.
The emerging understanding of L. johnsonii EF-Tu offers several promising research directions for microbiome studies:
Microbial adaption and host-microbe co-evolution:
Microbiome engineering and synthetic biology:
Developing engineered L. johnsonii strains with modified EF-Tu to enhance colonization capabilities
Creating chimeric probiotics with optimized adhesion and immunomodulatory properties
Designing "smart" probiotics that respond to specific intestinal microenvironments through pH-dependent EF-Tu binding
Microbiome-immune system interaction mapping:
Using EF-Tu as a model to understand how commensal bacteria communicate with the host immune system
Developing systems biology models of how bacterial surface proteins like EF-Tu contribute to gut homeostasis
Investigating the role of EF-Tu in training the mucosal immune system and establishing tolerance to commensals
Diagnostic applications:
Developing antibody-based assays targeting strain-specific EF-Tu epitopes for microbiome composition analysis
Creating biosensors that detect L. johnsonii colonization through EF-Tu recognition
Using EF-Tu sequence variants as biomarkers for host-adapted strains in microbiome samples
Therapeutic potential:
Exploring recombinant EF-Tu as a postbiotic agent that could provide benefits without requiring live bacteria
Investigating whether EF-Tu could be used to modulate specific immune responses in inflammatory conditions
Studying EF-Tu-derived peptides as potential immunomodulatory agents
These research directions leverage our understanding of EF-Tu's dual role in L. johnsonii as both a cytoplasmic protein involved in translation and a surface-expressed molecule involved in host interaction .
Advancing our understanding of the structural basis of EF-Tu host interactions requires several methodological innovations:
High-resolution structural analysis techniques:
Cryo-electron microscopy of EF-Tu bound to intestinal cell receptors or mucins
X-ray crystallography of EF-Tu in complex with host factors
NMR studies of the dynamic interactions between EF-Tu and host molecules
Hydrogen-deuterium exchange mass spectrometry to map binding interfaces
Advanced mutagenesis approaches:
Single-molecule interaction techniques:
Atomic force microscopy to measure binding forces
Single-molecule FRET to analyze conformational changes upon binding
Optical tweezers to characterize the mechanical properties of EF-Tu-mucin interactions
Total internal reflection fluorescence microscopy to visualize individual binding events
In situ imaging methods:
Super-resolution microscopy of EF-Tu distribution on L. johnsonii surface
Expansion microscopy to visualize EF-Tu interactions with intestinal tissue
Correlative light and electron microscopy to connect functional and structural data
Click chemistry-based approaches for in vivo labeling of EF-Tu interactions
Computational methods:
Molecular dynamics simulations of EF-Tu interactions with mucins and cell receptors
Machine learning approaches to predict binding interfaces from sequence data
Integrative modeling combining data from multiple experimental techniques
Systems biology models of how EF-Tu binding affects bacterial adhesion and host responses
These methodological advances would help resolve the structural determinants of the pH-dependent binding of EF-Tu to intestinal cells and mucins , as well as the potential basis for host specificity.
The emerging understanding of L. johnsonii EF-Tu offers valuable insights for designing next-generation probiotics with enhanced functionality:
Strain selection strategies:
Rational strain engineering approaches:
Modifying the tuf gene to enhance adhesion to specific intestinal regions
Engineering pH-responsive EF-Tu variants for targeted activity in different gut compartments
Creating strains with modified EF-Tu that selectively modulate specific immune pathways
Developing strains with controlled surface expression levels of EF-Tu
Combination probiotic design:
Formulating synbiotic combinations where EF-Tu-mediated adhesion is complemented by other beneficial properties
Creating defined multi-strain consortia with complementary EF-Tu immunomodulatory profiles
Designing strain combinations that collectively provide optimal EF-Tu-driven effects across varying gut conditions
Biomarker-guided personalization:
Using host genetic or microbiome biomarkers to match individuals with L. johnsonii strains having appropriate EF-Tu variants
Developing diagnostic tools to predict responsiveness to EF-Tu-mediated effects
Creating personalized probiotic regimens based on intestinal mucin profiles that interact optimally with specific EF-Tu variants
Delivery system optimization:
Designing encapsulation methods that protect L. johnsonii while allowing EF-Tu-mediated interactions upon release
Developing pH-triggered release systems that complement the natural pH-dependency of EF-Tu binding
Creating bioadhesive formulations that enhance EF-Tu-mucin interactions in specific intestinal regions
This knowledge-based approach to probiotic design moves beyond traditional empirical methods, leveraging the molecular understanding of how L. johnsonii interacts with the host through surface molecules like EF-Tu to create probiotics with enhanced efficacy and specificity.